Aryl Hydrocarbon Receptor Alleviates Hepatic Fibrosis by Inducing Hepatic Stellate Cell Ferroptosis
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.70278 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Shenghui Liu. Beteiligte Einrichtung: Lin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, China. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Ferroptosis, Receptors, Aryl Hydrocarbon, Liver Cirrhosis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Medical Health Science and Technology Project of Shandong Province.
Abstract (Originalsprache)
Liver injury‐induced activation of hepatic stellate cells (HSCs) is a crucial step in the progression of liver fibrosis. The aryl hydrocarbon receptor (AHR), a ligand‐activated transcription factor, is highly expressed in the liver. However, the role of AHR in liver fibrosis remains controversial. Our study revealed that the nontoxic ligand YH439 directly activated the AHR and regulated the expression of multidrug‐resistant protein 1 ( Mrp1 ) in mouse hepatic stellate cells (mHSCs), thereby diminishing the antioxidant capacity of mHSCs by promoting GSH efflux, and specifically inducing mHSCs ferroptosis without affecting hepatocytes. In a chronic liver fibrosis model, YH439 activated AHR to promote mHSC ferroptosis without causing hepatocyte ferroptosis, thereby alleviating liver fibrosis. Conclusively, this study shows that AHR alleviates liver fibrosis in mice by selectively inducing mHSC ferroptosis without causing hepatocyte ferroptosis and suggests that AHR is a potential target for the treatment of liver fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, China.
ORCID-Profile: Shenghui Liu
Förderung
- The Medical Health Science and Technology Project of Shandong Province
Zitieren
APA
Liu, S. (2024). Aryl Hydrocarbon Receptor Alleviates Hepatic Fibrosis by Inducing Hepatic Stellate Cell Ferroptosis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70278
Vancouver
Liu S. Aryl Hydrocarbon Receptor Alleviates Hepatic Fibrosis by Inducing Hepatic Stellate Cell Ferroptosis. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70278
BibTeX
@article{Liu2024,
author = {Liu, Shenghui},
title = {Aryl Hydrocarbon Receptor Alleviates Hepatic Fibrosis by Inducing Hepatic Stellate Cell Ferroptosis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.70278}
}
EUVIMED